Viewing nowCombinationRostel Plus Tablets 40/5/10 milligrams
Telmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Samchundang Pharm Co., Ltd.

MFDS item code 202302007 · Approved 2023.06.29 · Insurance code 651206080
Treatment of hypertension and dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure even with the administration of telmisartan and amlodipine. Additionally, rosuvastatin is used as an adjunctive treatment for patients with hypercholesterolemia and dyslipidemia when dietary control and exercise are insufficient. This medication helps lower total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, delays the progression of atherosclerosis, and reduces the risk of cardiovascular diseases. Particularly, it is effective in reducing the risk of stroke, myocardial infarction, and vascular revascularization in middle-aged or older patients with cardiovascular disease risk factors. This medication is effectively used for the treatment of hypertension and dyslipidemia.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. Patients taking the telmisartan/amlodipine combination together with rosuvastatin as a single agent may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the doses of the individual components (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. - 80/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or this medicine 40/10 milligrams. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 milligrams. ◦ Older adults: In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients receiving rosuvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted for maintenance treatment. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients.
This medication can cause severe harm to the fetus and newborn and should be discontinued immediately upon confirmation of pregnancy. Avoid taking if allergic to any ingredients in this medication or similar drugs. Administration should be avoided in patients with severe liver or kidney dysfunction, certain heart diseases, and those with a history of angioedema. Special caution is required for elderly patients, patients with impaired liver function, and patients with excessively low blood pressure. If symptoms such as muscle pain, muscle weakness, or muscle cramps occur, consult a physician promptly, and discontinue use if severe. The risk of side effects may increase when taking this medication with other specific drugs, so patients should inform their doctor or pharmacist if they are taking any other medications. Women of childbearing potential should use appropriate contraceptive methods while taking this medication, and it is advised not to take it while breastfeeding. The safety and efficacy of this medication have not been sufficiently established for children and adolescents under 18, and it is not recommended in these populations. In case of overdose, symptoms such as hypotension, dizziness, and arrhythmias may occur, so medical assistance should be sought immediately. This medication should be stored in a cool, dry place away from direct sunlight and kept out of reach of children.
Peripheral edema, dyspepsia, frequent bowel movements, diabetes, dizziness, dry vesicular sounds, urticaria, unstable angina, onychomycosis, lumbar spinal canal stenosis, ear fluid, vertigo, chronic gastritis, hiatal hernia, dysuria, rhinitis, discomfort in the oropharynx, pulmonary disease, unspecified gastrointestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory infection, back pain, sinusitis, diarrhea, pharyngitis, influenza-like symptoms, dyspepsia, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, cough, hypertension, chest pain, nausea, peripheral edema, autonomic nervous system abnormalities (erectile dysfunction, increased sweating, flushing), systemic abnormalities (allergy, fever, leg pain, malaise), cardiovascular abnormalities (palpitations, dependency edema, angina, rapid pulse, leg edema, abnormal ECG), central nervous system abnormalities (insomnia, drowsiness, migraine, dizziness, sensory abnormalities, involuntary muscle contraction, sensory impairment), gastrointestinal abnormalities (flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disease), metabolic abnormalities (gout, hypercholesterolemia, diabetes), musculoskeletal abnormalities (arthritis, joint pain, leg numbness), psychiatric abnormalities (anxiety, depression, nervous irritation), tolerance mechanism abnormalities (infection, fungal infection, abscess, otitis media), respiratory system abnormalities (asthma, bronchitis, rhinitis, shortness of breath, nosebleed), skin abnormalities (dermatitis, rash, eczema, itching), urological system abnormalities (frequent urination, cystitis), vascular abnormalities (cerebrovascular disease), special sensory abnormalities (visual disturbances, conjunctivitis, tinnitus, ear pain), vascular edema, headache, edema, dizziness, flushing, palpitations, fatigue, nausea, abdominal pain, drowsiness, arrhythmia, bradycardia, chest pain, peripheral ischemia, syncope, orthostatic hypotension, vasculitis, peripheral neuropathy, sensory abnormalities, tremors, dizziness, loss of appetite, constipation, dysphagia, diarrhea, flatulence, pancreatitis, vomiting, gingival hyperplasia, allergic reactions, back pain, burning sensation, malaise, pain, stiffness, weight gain, weight loss, joint pain, arthropathy, muscle cramps, myalgia, erectile dysfunction, insomnia, nervous irritability, depression, abnormal dreams, anxiety, depersonalization, shortness of breath, nosebleed, vascular edema, polymorphic erythema, itching, rash, erythematous rash, papular rash, frequent urination, urinary dysfunction, nocturnal enuresis, dry mouth, increased sweating, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, hypersensitivity reactions including vascular edema, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe myasthenia gravis, ocular myasthenia
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a light-protective, tightly closed container. It is recommended to maintain a storage temperature between 1°C and 30°C. Proper storage can help maintain the effectiveness and safety of the medication for a long time.
Oval, bicolored tablets consisting of a white layer and a light blue layer
For domestic use - 30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Samchundang Pharm Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myeong Mun Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.